| Product |
CAS |
Molecular formula |
More |
| Pyrazinecarboxamide, 5-(1-methylethyl)-(9ci) |
111035-35-9 |
C8H11N3O |
More |
| Pyrazinecarboxamide, 5-acetyl-(9ci) |
147425-79-4 |
C7H7N3O2 |
More |
| Pyrazinecarboxamide, 5-ethyl-3,4-dihydro-6-methyl-3-oxo-(9ci) |
440124-21-0 |
C8H11N3O2 |
More |
| Pyrazinecarboxamide, 5-methyl-n-(1-methylethyl)-(9ci) |
606096-82-6 |
C9H13N3O |
More |
| Pyrazinecarboxamide, 5-methyl-n-(2-phenyl-2h-benzotriazol-5-yl)-(9ci) |
606096-89-3 |
C18H14N6O |
More |
| Pyrazinecarboxamide, 5-methyl-n-(5-methyl-1,3,4-thiadiazol-2-yl)-(9ci) |
606096-90-6 |
C9H9N5OS |
More |
| Pyrazinecarboxamide, 5-methyl-n-[4-(1h-tetrazol-1-yl)phenyl]-(9ci) |
606096-91-7 |
C13H11N7O |
More |
| Pyrazinecarboxamide, 5-methyl-n-[4-(1-methylethyl)phenyl]-(9ci) |
721426-27-3 |
C15H17N3O |
More |
| Pyrazinecarboxamide, 5-methyl-n-[4-(1-pyrrolidinylcarbonyl)phenyl]-(9c |
606096-83-7 |
C17H18N4O2 |
More |
| Pyrazinecarboxamide, 5-methyl-n-[4-(4-morpholinyl)phenyl]-(9ci) |
606132-22-3 |
C16H18N4O2 |
More |
| Pyrazinecarboxamide, 5-methyl-n-[4-[[(1-methylethyl)amino]sulfonyl]phe |
603945-75-1 |
C15H18N4O3S |
More |
| Pyrazinecarboxamide, 5-methyl-n-[4-[[(2-methylpropyl)amino]sulfonyl]ph |
603945-73-9 |
C16H20N4O3S |
More |
| Pyrazinecarboxamide, 5-methyl-n-[4-[[[(tetrahydro-2-furanyl)methyl]ami |
603945-80-8 |
C17H20N4O4S |
More |
| Pyrazinecarboxamide, 5-methyl-n-[5-(1-methylethyl)-1,3,4-thiadiazol-2- |
606096-81-5 |
C11H13N5OS |
More |
| Pyrazinecarboxamide, 5-methyl-n-3-quinolinyl-(9ci) |
606096-92-8 |
C15H12N4O |
More |
| Pyrazinecarboxamide, 5-methyl-n-8-quinolinyl-(9ci) |
606096-88-2 |
C15H12N4O |
More |
| Pyrazinecarboxamide, 6-[(2-aminoethyl)amino]-n-1h-tetrazol-5-yl-(9ci) |
765237-25-0 |
C8H11N9O |
More |
| Pyrazinecarboxamide, 6-ethyl-3,4-dihydro-5-methyl-3-oxo-(9ci) |
440124-22-1 |
C8H11N3O2 |
More |
| Pyrazinecarboxamide, n-(1,3-benzodioxol-5-ylmethyl)-5-methyl-(9ci) |
606096-87-1 |
C14H13N3O3 |
More |
| Pyrazinecarboxamide, n-(1-oxopropyl)-(9ci) |
140670-54-8 |
C8H9N3O2 |
More |
